应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
LNTH Lantheus Holdings, Inc.
休市中 04-04 16:00:00 EDT
90.92
-6.29
-6.47%
盘后
90.92
+0.00
0.00%
17:20 EDT
最高
93.86
最低
89.12
成交量
115.83万
今开
92.49
昨收
97.21
日振幅
4.87%
总市值
62.38亿
流通市值
56.33亿
总股本
6,861万
成交额
1.06亿
换手率
1.87%
流通股本
6,195万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
Lantheus Holdings, Inc.涨2.00% 股价突破100美元大关
市场透视 · 03-05
Lantheus Holdings, Inc.涨2.00% 股价突破100美元大关
Lantheus Holdings, Inc.2024财年实现净利润3.12亿美元,同比减少4.59%
市场透视 · 03-02
Lantheus Holdings, Inc.2024财年实现净利润3.12亿美元,同比减少4.59%
异动解读 | 2024年业绩超出预期,朗修盘中大涨5.15%
异动解读 · 02-26
异动解读 | 2024年业绩超出预期,朗修盘中大涨5.15%
Lantheus Holdings, Inc.盘中异动 早盘股价大涨5.35%报84.33美元
市场透视 · 02-26
Lantheus Holdings, Inc.盘中异动 早盘股价大涨5.35%报84.33美元
朗修预期2025年营收为15.45亿至16.1亿美元,市场预期为16.05亿美元,调整后每股收益为7.00至7.20美元,市场预期为6.95美元
财报速递 · 02-26
朗修预期2025年营收为15.45亿至16.1亿美元,市场预期为16.05亿美元,调整后每股收益为7.00至7.20美元,市场预期为6.95美元
Lantheus Holdings 2024年第四季度调整后每股收益为$1.59,超出预期的$1.53,销售额为$391.10M,超出预期的$375.43M
财报速递 · 02-26
Lantheus Holdings 2024年第四季度调整后每股收益为$1.59,超出预期的$1.53,销售额为$391.10M,超出预期的$375.43M
Lantheus Holdings, Inc.盘中异动 股价大涨5.02%
市场透视 · 02-18
Lantheus Holdings, Inc.盘中异动 股价大涨5.02%
Lantheus Holdings, Inc.盘中异动 股价大跌5.09%
市场透视 · 02-11
Lantheus Holdings, Inc.盘中异动 股价大跌5.09%
Lantheus Holdings, Inc.盘中异动 快速下挫5.08%
市场透视 · 02-03
Lantheus Holdings, Inc.盘中异动 快速下挫5.08%
Lantheus Holdings, Inc.涨1.72% 股价突破100美元大关
市场透视 · 01-28
Lantheus Holdings, Inc.涨1.72% 股价突破100美元大关
Lantheus重申2024财年收入为15.1亿至15.2亿美元,调整后的每股收益为6.65至6.70美元,分别低于市场预期的15.2亿美元和6.74美元
财报速递 · 01-28
Lantheus重申2024财年收入为15.1亿至15.2亿美元,调整后的每股收益为6.65至6.70美元,分别低于市场预期的15.2亿美元和6.74美元
Lantheus Holdings, Inc.盘中异动 股价大跌5.04%
市场透视 · 01-13
Lantheus Holdings, Inc.盘中异动 股价大跌5.04%
Lantheus Holdings, Inc.盘中异动 股价大涨5.95%报84.16美元
市场透视 · 2024-11-20
Lantheus Holdings, Inc.盘中异动 股价大涨5.95%报84.16美元
Lantheus Holdings, Inc.盘中异动 急速跳水5.05%
市场透视 · 2024-11-15
Lantheus Holdings, Inc.盘中异动 急速跳水5.05%
Lantheus Holdings, Inc.2024财年第三财季实现净利润1.31亿美元,同比减少0.76%
市场透视 · 2024-11-14
Lantheus Holdings, Inc.2024财年第三财季实现净利润1.31亿美元,同比减少0.76%
Lantheus Holdings, Inc.盘中异动 股价大跌5.07%报80.84美元
市场透视 · 2024-11-13
Lantheus Holdings, Inc.盘中异动 股价大跌5.07%报80.84美元
Lantheus Holdings, Inc.盘中异动 股价大跌5.62%报82.58美元
市场透视 · 2024-11-11
Lantheus Holdings, Inc.盘中异动 股价大跌5.62%报82.58美元
Lantheus Holdings, Inc.盘中异动 股价大跌15.98%报96.59美元
市场透视 · 2024-11-06
Lantheus Holdings, Inc.盘中异动 股价大跌15.98%报96.59美元
Lantheus Holdings, Inc.盘中异动 急速拉升5.45%报113.87美元
市场透视 · 2024-11-04
Lantheus Holdings, Inc.盘中异动 急速拉升5.45%报113.87美元
Lantheus Holdings, Inc.盘中异动 股价大跌5.00%报110.86美元
市场透视 · 2024-10-21
Lantheus Holdings, Inc.盘中异动 股价大跌5.00%报110.86美元
加载更多
公司概况
公司名称:
Lantheus Holdings, Inc.
所属市场:
NASDAQ
上市日期:
--
主营业务:
Lantheus Holdings, Inc.于2007年成立于特拉华州,总部在马萨诸塞州的北比尔里卡。公司是从事开发、生产、销售及分销创新医学影像诊断试剂和产品,协助临床医生在心血管和其他疾病的诊断的全球领导者。公司的试剂通常用于诊断冠状动脉疾病、充血性心脏衰竭、中风、外周血管疾病和其他疾病。临床医生使用公司的显像剂和产品通过一系列的成像方式,包括核成像、超声心动图和磁共振成像,或核磁共振。公司相信改进的诊断信息能够使医疗服务提供更好的检测和表征,或排除疾病,可能实现改善病人状况、减少病人风险和限制纳税人整体成本和整个医疗体系。
发行价格:
--
{"stockData":{"symbol":"LNTH","market":"US","secType":"STK","nameCN":"Lantheus Holdings, Inc.","latestPrice":90.92,"timestamp":1743796800000,"preClose":97.21,"halted":0,"volume":1158346,"hourTrading":{"tag":"盘后","latestPrice":90.92,"preClose":90.92,"latestTime":"17:20 EDT","volume":2290,"amount":208191.22,"timestamp":1743801639711},"delay":0,"floatShares":61951087,"shares":68611303,"eps":4.36,"marketStatus":"休市中","change":-6.29,"latestTime":"04-04 16:00:00 EDT","open":92.49,"high":93.8585,"low":89.12,"amount":105586075.8477,"amplitude":0.048745,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":4.36,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1744012800000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":1435204800000,"exchange":"NASDAQ","adjPreClose":97.21,"preHourTrading":{"tag":"盘前","latestPrice":92.19,"preClose":97.21,"latestTime":"09:29 EDT","volume":1777,"amount":166368.92396000001,"timestamp":1743773399999},"postHourTrading":{"tag":"盘后","latestPrice":90.92,"preClose":90.92,"latestTime":"17:20 EDT","volume":2290,"amount":208191.22,"timestamp":1743801639711},"volumeRatio":1.5710885608636873,"impliedVol":0.7526,"impliedVolPercentile":0.9323},"requestUrl":"/m/hq/s/LNTH","defaultTab":"news","newsList":[{"id":"2517943630","title":"Lantheus Holdings, Inc.涨2.00% 股价突破100美元大关","url":"https://stock-news.laohu8.com/highlight/detail?id=2517943630","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517943630?lang=zh_cn&edition=full","pubTime":"2025-03-05 22:49","pubTimestamp":1741186195,"startTime":"0","endTime":"0","summary":"北京时间2025年03月05日22时49分,Lantheus Holdings, Inc.股票出现波动,股价大幅上涨2.00%。Lantheus Holdings, Inc.股票所在的制药行业中,整体涨幅为0.79%。Lantheus Holdings, Inc.公司简介:Lantheus Holdings Inc 通过开发诊断产品迎合美国医疗保健行业的需求。战略合作伙伴关系侧重于通过使用生物标志物、数字解决方案和制药服务平台实现精准医疗,还包括向 Bausch Health Companies, Inc 授予 RELISTOR 许可。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305224955a260ce20&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305224955a260ce20&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4198","LNTH","BK4588","BK4585"],"gpt_icon":0},{"id":"2516548063","title":"Lantheus Holdings, Inc.2024财年实现净利润3.12亿美元,同比减少4.59%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516548063","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2516548063?lang=zh_cn&edition=full","pubTime":"2025-03-03 00:00","pubTimestamp":1740931236,"startTime":"0","endTime":"0","summary":"3月3日,Lantheus Holdings, Inc.公布财报,公告显示公司2024财年净利润为3.12亿美元,同比减少4.59%;其中营业收入为15.34亿美元,同比增加18.36%,每股基本收益为4.52美元。机构评级:截至2025年3月3日,当前有14家机构对Lantheus Holdings, Inc.目标价做出预测,其中目标均价为131.11美元,其中最低目标价为94.50美元,最高目标价为166.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303000056abe4aca3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303000056abe4aca3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LNTH"],"gpt_icon":0},{"id":"1178569921","title":"异动解读 | 2024年业绩超出预期,朗修盘中大涨5.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=1178569921","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1178569921?lang=zh_cn&edition=full","pubTime":"2025-02-26 22:43","pubTimestamp":1740581038,"startTime":"0","endTime":"0","summary":"朗修控股(LNTH)今日盘中大涨5.15%,引起了市场的广泛关注。\n\n消息面上,朗修公布了2024年第四季度业绩,每股收益为1.59美元,高于分析师预期的1.53美元,增长3.92%;季度销售额为3.911亿美元,也超出分析师预期的3.754亿美元,增长4.17%。\n\n另外,该公司还发布了2025年的业绩预期,预计全年营收为15.45亿至16.1亿美元,市场之前预期为16.05亿美元;预计调整后每股收益为7.00至7.20美元,高于市场预期的6.95美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["LNTH"],"gpt_icon":0},{"id":"2514856927","title":"Lantheus Holdings, Inc.盘中异动 早盘股价大涨5.35%报84.33美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514856927","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514856927?lang=zh_cn&edition=full","pubTime":"2025-02-26 22:31","pubTimestamp":1740580290,"startTime":"0","endTime":"0","summary":"北京时间2025年02月26日22时31分,Lantheus Holdings, Inc.股票出现波动,股价大幅拉升5.35%。Lantheus Holdings, Inc.股票所在的制药行业中,整体跌幅为0.13%。Lantheus Holdings, Inc.公司简介:Lantheus Holdings Inc 通过开发诊断产品迎合美国医疗保健行业的需求。战略合作伙伴关系侧重于通过使用生物标志物、数字解决方案和制药服务平台实现精准医疗,还包括向 Bausch Health Companies, Inc 授予 RELISTOR 许可。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022622313096314f22&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022622313096314f22&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4588","LNTH","BK4198","BK4585"],"gpt_icon":0},{"id":"1106584934","title":"朗修预期2025年营收为15.45亿至16.1亿美元,市场预期为16.05亿美元,调整后每股收益为7.00至7.20美元,市场预期为6.95美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1106584934","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1106584934?lang=zh_cn&edition=full","pubTime":"2025-02-26 20:08","pubTimestamp":1740571700,"startTime":"0","endTime":"0","summary":"朗修预期2025年营收为15.45亿至16.1亿美元,市场预期为16.05亿美元,调整后每股收益为7.00至7.20美元,市场预期为6.95美元。以上内容来自Benzinga Earnings专栏,原文如下:Lantheus Forecasts 2025 Revenues Of $1.545B-$1.61B Vs. Consensus Of $1.605B, With Adjusted EPS Of $7.00-$7.20 Vs. $6.95 Est.","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LNTH"],"gpt_icon":0},{"id":"1144016372","title":"Lantheus Holdings 2024年第四季度调整后每股收益为$1.59,超出预期的$1.53,销售额为$391.10M,超出预期的$375.43M","url":"https://stock-news.laohu8.com/highlight/detail?id=1144016372","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1144016372?lang=zh_cn&edition=full","pubTime":"2025-02-26 20:03","pubTimestamp":1740571427,"startTime":"0","endTime":"0","summary":"Lantheus Holdings 报告其季度每股收益为$1.59,高于分析师预期的$1.53,超出预期3.92%。与去年同期的$1.75相比,这是一个9.14%的下降。与去年同期的$354.00M相比,这一销售额增长了10.48%。以上内容来自Benzinga Earnings专栏,原文如下:Lantheus Holdings reported quarterly earnings of $1.59 per share which beat the analyst consensus estimate of $1.53 by 3.92 percent. This is a 9.14 percent decrease over earnings of $1.75 per share from the same period last year. The company reported quarterly sales of $391.10 million which beat the analyst consensus estimate of $375.43 million by","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Lantheus Holdings 2024年第四季度调整后每股收益为$1.59,超出预期的$1.53,销售额为$391.10M,超出预期的$375.43M","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LNTH"],"gpt_icon":1},{"id":"2512196489","title":"Lantheus Holdings, Inc.盘中异动 股价大涨5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2512196489","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2512196489?lang=zh_cn&edition=full","pubTime":"2025-02-19 02:49","pubTimestamp":1739904545,"startTime":"0","endTime":"0","summary":"北京时间2025年02月19日02时49分,Lantheus Holdings, Inc.股票出现波动,股价急速上涨5.02%。Lantheus Holdings, Inc.股票所在的制药行业中,整体涨幅为1.84%。Lantheus Holdings, Inc.公司简介:Lantheus Holdings Inc 通过开发诊断产品迎合美国医疗保健行业的需求。Precision Diagnostic 产品帮助医疗保健专业人员查找和跟踪疾病,重点是心脏病学。战略合作伙伴关系侧重于通过使用生物标志物、数字解决方案和制药服务平台实现精准医疗,还包括向 Bausch Health Companies, Inc 授予 RELISTOR 许可。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219024906a24ae2c3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219024906a24ae2c3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4588","BK4198","BK4585","LNTH"],"gpt_icon":0},{"id":"2510521873","title":"Lantheus Holdings, Inc.盘中异动 股价大跌5.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2510521873","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2510521873?lang=zh_cn&edition=full","pubTime":"2025-02-12 04:43","pubTimestamp":1739306624,"startTime":"0","endTime":"0","summary":"北京时间2025年02月12日04时43分,Lantheus Holdings, Inc.股票出现波动,股价急速下跌5.09%。Lantheus Holdings, Inc.股票所在的制药行业中,整体涨幅为0.07%。Lantheus Holdings, Inc.公司简介:Lantheus Holdings Inc 通过开发诊断产品迎合美国医疗保健行业的需求。Precision Diagnostic 产品帮助医疗保健专业人员查找和跟踪疾病,重点是心脏病学。战略合作伙伴关系侧重于通过使用生物标志物、数字解决方案和制药服务平台实现精准医疗,还包括向 Bausch Health Companies, Inc 授予 RELISTOR 许可。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502120443459881f7fb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502120443459881f7fb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LNTH","BK4588","BK4198","BK4585"],"gpt_icon":0},{"id":"2508853129","title":"Lantheus Holdings, Inc.盘中异动 快速下挫5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2508853129","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2508853129?lang=zh_cn&edition=full","pubTime":"2025-02-04 01:59","pubTimestamp":1738605560,"startTime":"0","endTime":"0","summary":"北京时间2025年02月04日01时59分,Lantheus Holdings, Inc.股票出现异动,股价大幅跳水5.08%。Lantheus Holdings, Inc.股票所在的制药行业中,整体跌幅为0.24%。Lantheus Holdings, Inc.公司简介:Lantheus Holdings Inc 通过开发诊断产品迎合美国医疗保健行业的需求。Precision Diagnostic 产品帮助医疗保健专业人员查找和跟踪疾病,重点是心脏病学。战略合作伙伴关系侧重于通过使用生物标志物、数字解决方案和制药服务平台实现精准医疗,还包括向 Bausch Health Companies, Inc 授予 RELISTOR 许可。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250204015921a2383257&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250204015921a2383257&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4588","BK4585","BK4198","LNTH"],"gpt_icon":0},{"id":"2506951437","title":"Lantheus Holdings, Inc.涨1.72% 股价突破100美元大关","url":"https://stock-news.laohu8.com/highlight/detail?id=2506951437","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2506951437?lang=zh_cn&edition=full","pubTime":"2025-01-28 22:31","pubTimestamp":1738074686,"startTime":"0","endTime":"0","summary":"北京时间2025年01月28日22时31分,Lantheus Holdings, Inc.股票出现波动,股价快速上涨1.72%。Lantheus Holdings, Inc.股票所在的制药行业中,整体跌幅为0.01%。Lantheus Holdings, Inc.公司简介:Lantheus Holdings Inc 通过开发诊断产品迎合美国医疗保健行业的需求。Precision Diagnostic 产品帮助医疗保健专业人员查找和跟踪疾病,重点是心脏病学。战略合作伙伴关系侧重于通过使用生物标志物、数字解决方案和制药服务平台实现精准医疗,还包括向 Bausch Health Companies, Inc 授予 RELISTOR 许可。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250128223126abbb65ac&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250128223126abbb65ac&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4198","BK4588","BK4585","LNTH"],"gpt_icon":0},{"id":"1194957767","title":"Lantheus重申2024财年收入为15.1亿至15.2亿美元,调整后的每股收益为6.65至6.70美元,分别低于市场预期的15.2亿美元和6.74美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1194957767","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1194957767?lang=zh_cn&edition=full","pubTime":"2025-01-28 19:08","pubTimestamp":1738062494,"startTime":"0","endTime":"0","summary":"Lantheus重申2024财年收入为15.1亿至15.2亿美元,调整后的每股收益为6.65至6.70美元,分别低于市场预期的15.2亿美元和6.74美元以上内容来自Benzinga Earnings专栏,原文如下:Lantheus Reaffirms FY 2024 Revenue Of $1.51B-$1.52B, And Adjusted EPS Of $6.65-$6.70 Compared To Consensus Of $1.52B And $6.74, Respectively","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Lantheus重申2024财年收入为15.1亿至15.2亿美元,调整后的每股收益为6.65至6.70美元,分别低于市场预期的15.2亿美元和6.74美元","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LNTH"],"gpt_icon":0},{"id":"2503658914","title":"Lantheus Holdings, Inc.盘中异动 股价大跌5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2503658914","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2503658914?lang=zh_cn&edition=full","pubTime":"2025-01-13 22:37","pubTimestamp":1736779020,"startTime":"0","endTime":"0","summary":"北京时间2025年01月13日22时37分,Lantheus Holdings, Inc.股票出现异动,股价快速下挫5.04%。Lantheus Holdings, Inc.股票所在的制药行业中,整体跌幅为0.30%。Lantheus Holdings, Inc.公司简介:Lantheus Holdings Inc 通过开发诊断产品迎合美国医疗保健行业的需求。Precision Diagnostic 产品帮助医疗保健专业人员查找和跟踪疾病,重点是心脏病学。战略合作伙伴关系侧重于通过使用生物标志物、数字解决方案和制药服务平台实现精准医疗,还包括向 Bausch Health Companies, Inc 授予 RELISTOR 许可。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025011322370196025423&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025011322370196025423&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4588","LNTH","BK4198","BK4585"],"gpt_icon":0},{"id":"2484611089","title":"Lantheus Holdings, Inc.盘中异动 股价大涨5.95%报84.16美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2484611089","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2484611089?lang=zh_cn&edition=full","pubTime":"2024-11-20 22:31","pubTimestamp":1732113070,"startTime":"0","endTime":"0","summary":"北京时间2024年11月20日22时31分,Lantheus Holdings, Inc.股票出现异动,股价大幅拉升5.95%。Lantheus Holdings, Inc.股票所在的制药行业中,整体涨幅为0.47%。Lantheus Holdings, Inc.公司简介:Lantheus Holdings Inc 通过开发诊断产品迎合美国医疗保健行业的需求。Precision Diagnostic 产品帮助医疗保健专业人员查找和跟踪疾病,重点是心脏病学。战略合作伙伴关系侧重于通过使用生物标志物、数字解决方案和制药服务平台实现精准医疗,还包括向 Bausch Health Companies, Inc 授予 RELISTOR 许可。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112022311198e43bc8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112022311198e43bc8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LNTH","BK4585","BK4198","BK4588"],"gpt_icon":0},{"id":"2483580938","title":"Lantheus Holdings, Inc.盘中异动 急速跳水5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483580938","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2483580938?lang=zh_cn&edition=full","pubTime":"2024-11-16 04:38","pubTimestamp":1731703099,"startTime":"0","endTime":"0","summary":"北京时间2024年11月16日04时38分,Lantheus Holdings, Inc.股票出现异动,股价大幅下跌5.05%。Lantheus Holdings, Inc.股票所在的制药行业中,整体跌幅为3.03%。Lantheus Holdings, Inc.公司简介:Lantheus Holdings Inc 通过开发诊断产品迎合美国医疗保健行业的需求。Precision Diagnostic 产品帮助医疗保健专业人员查找和跟踪疾病,重点是心脏病学。战略合作伙伴关系侧重于通过使用生物标志物、数字解决方案和制药服务平台实现精准医疗,还包括向 Bausch Health Companies, Inc 授予 RELISTOR 许可。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241116043819a23c03c4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241116043819a23c03c4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LNTH","BK4198","BK4588","BK4585"],"gpt_icon":0},{"id":"2483385871","title":"Lantheus Holdings, Inc.2024财年第三财季实现净利润1.31亿美元,同比减少0.76%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483385871","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2483385871?lang=zh_cn&edition=full","pubTime":"2024-11-15 00:00","pubTimestamp":1731600056,"startTime":"0","endTime":"0","summary":"11月15日,Lantheus Holdings, Inc.公布财报,公告显示公司2024财年第三财季净利润为1.31亿美元,同比减少0.76%;其中营业收入为3.79亿美元,同比增加18.44%,每股基本收益为1.89美元。机构评级:截至2024年11月15日,当前有11家机构对Lantheus Holdings, Inc.目标价做出预测,其中目标均价为134.00美元,其中最低目标价为110.00美元,最高目标价为166.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241115000118abc188f1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241115000118abc188f1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LNTH"],"gpt_icon":0},{"id":"2483285493","title":"Lantheus Holdings, Inc.盘中异动 股价大跌5.07%报80.84美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483285493","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2483285493?lang=zh_cn&edition=full","pubTime":"2024-11-14 03:58","pubTimestamp":1731527913,"startTime":"0","endTime":"0","summary":"北京时间2024年11月14日03时58分,Lantheus Holdings, Inc.股票出现异动,股价急速下挫5.07%。Lantheus Holdings, Inc.股票所在的制药行业中,整体跌幅为0.54%。Lantheus Holdings, Inc.公司简介:Lantheus Holdings Inc 通过开发诊断产品迎合美国医疗保健行业的需求。Precision Diagnostic 产品帮助医疗保健专业人员查找和跟踪疾病,重点是心脏病学。战略合作伙伴关系侧重于通过使用生物标志物、数字解决方案和制药服务平台实现精准医疗,还包括向 Bausch Health Companies, Inc 授予 RELISTOR 许可。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114035834971a65e0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114035834971a65e0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LNTH","BK4198","BK4588","BK4585"],"gpt_icon":0},{"id":"2482973817","title":"Lantheus Holdings, Inc.盘中异动 股价大跌5.62%报82.58美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2482973817","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2482973817?lang=zh_cn&edition=full","pubTime":"2024-11-11 22:35","pubTimestamp":1731335759,"startTime":"0","endTime":"0","summary":"北京时间2024年11月11日22时35分,Lantheus Holdings, Inc.股票出现波动,股价急速下挫5.62%。Lantheus Holdings, Inc.股票所在的制药行业中,整体跌幅为0.64%。Lantheus Holdings, Inc.公司简介:Lantheus Holdings Inc 通过开发诊断产品迎合美国医疗保健行业的需求。战略合作伙伴关系侧重于通过使用生物标志物、数字解决方案和制药服务平台实现精准医疗,还包括向 Bausch Health Companies, Inc 授予 RELISTOR 许可。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111122355998e41c84&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111122355998e41c84&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","LNTH","BK4198","BK4588"],"gpt_icon":0},{"id":"2481989327","title":"Lantheus Holdings, Inc.盘中异动 股价大跌15.98%报96.59美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2481989327","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2481989327?lang=zh_cn&edition=full","pubTime":"2024-11-06 22:33","pubTimestamp":1730903595,"startTime":"0","endTime":"0","summary":"北京时间2024年11月06日22时33分,Lantheus Holdings, Inc.股票出现波动,股价快速跳水15.98%。Lantheus Holdings, Inc.股票所在的制药行业中,整体涨幅为0.78%。Lantheus Holdings, Inc.公司简介:Lantheus Holdings Inc 通过开发诊断产品迎合美国医疗保健行业的需求。战略合作伙伴关系侧重于通过使用生物标志物、数字解决方案和制药服务平台实现精准医疗,还包括向 Bausch Health Companies, Inc 授予 RELISTOR 许可。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110622331595bddb9c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110622331595bddb9c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4198","BK4585","BK4588","LNTH"],"gpt_icon":0},{"id":"2480587692","title":"Lantheus Holdings, Inc.盘中异动 急速拉升5.45%报113.87美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2480587692","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2480587692?lang=zh_cn&edition=full","pubTime":"2024-11-04 22:48","pubTimestamp":1730731681,"startTime":"0","endTime":"0","summary":"北京时间2024年11月04日22时48分,Lantheus Holdings, Inc.股票出现异动,股价快速上涨5.45%。Lantheus Holdings, Inc.股票所在的制药行业中,整体涨幅为0.00%。Lantheus Holdings, Inc.公司简介:Lantheus Holdings Inc 通过开发诊断产品迎合美国医疗保健行业的需求。Precision Diagnostic 产品帮助医疗保健专业人员查找和跟踪疾病,重点是心脏病学。战略合作伙伴关系侧重于通过使用生物标志物、数字解决方案和制药服务平台实现精准医疗,还包括向 Bausch Health Companies, Inc 授予 RELISTOR 许可。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110422480198e404b8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110422480198e404b8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","LNTH","BK4588","BK4198"],"gpt_icon":0},{"id":"2477689213","title":"Lantheus Holdings, Inc.盘中异动 股价大跌5.00%报110.86美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2477689213","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2477689213?lang=zh_cn&edition=full","pubTime":"2024-10-22 02:12","pubTimestamp":1729534378,"startTime":"0","endTime":"0","summary":"北京时间2024年10月22日02时12分,Lantheus Holdings, Inc.股票出现波动,股价大幅下跌5.00%。Lantheus Holdings, Inc.股票所在的制药行业中,整体跌幅为0.81%。Lantheus Holdings, Inc.公司简介:Lantheus Holdings Inc 通过开发诊断产品迎合美国医疗保健行业的需求。Precision Diagnostic 产品帮助医疗保健专业人员查找和跟踪疾病,重点是心脏病学。战略合作伙伴关系侧重于通过使用生物标志物、数字解决方案和制药服务平台实现精准医疗,还包括向 Bausch Health Companies, Inc 授予 RELISTOR 许可。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241022021258a1e25d0d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241022021258a1e25d0d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LNTH","BK4585","BK4198","BK4588"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.lantheus.com","stockEarnings":[{"period":"1week","weight":-0.0545},{"period":"1month","weight":-0.0951},{"period":"3month","weight":-0.0032},{"period":"6month","weight":-0.1565},{"period":"1year","weight":0.5209},{"period":"ytd","weight":0.0163}],"compareEarnings":[{"period":"1week","weight":-0.0907},{"period":"1month","weight":-0.1334},{"period":"3month","weight":-0.1464},{"period":"6month","weight":-0.1182},{"period":"1year","weight":-0.0152},{"period":"ytd","weight":-0.1379}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Lantheus Holdings, Inc.于2007年成立于特拉华州,总部在马萨诸塞州的北比尔里卡。公司是从事开发、生产、销售及分销创新医学影像诊断试剂和产品,协助临床医生在心血管和其他疾病的诊断的全球领导者。公司的试剂通常用于诊断冠状动脉疾病、充血性心脏衰竭、中风、外周血管疾病和其他疾病。临床医生使用公司的显像剂和产品通过一系列的成像方式,包括核成像、超声心动图和磁共振成像,或核磁共振。公司相信改进的诊断信息能够使医疗服务提供更好的检测和表征,或排除疾病,可能实现改善病人状况、减少病人风险和限制纳税人整体成本和整个医疗体系。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":-0.02308},{"month":2,"riseRate":0.7,"avgChangeRate":0.198411},{"month":3,"riseRate":0.6,"avgChangeRate":0.020838},{"month":4,"riseRate":0.8,"avgChangeRate":0.060447},{"month":5,"riseRate":0.666667,"avgChangeRate":0.039247},{"month":6,"riseRate":0.666667,"avgChangeRate":0.139951},{"month":7,"riseRate":0.6,"avgChangeRate":0.057405},{"month":8,"riseRate":0.5,"avgChangeRate":0.094453},{"month":9,"riseRate":0.4,"avgChangeRate":-0.048376},{"month":10,"riseRate":0.4,"avgChangeRate":-0.062278},{"month":11,"riseRate":0.8,"avgChangeRate":0.081936},{"month":12,"riseRate":0.3,"avgChangeRate":-0.057864}],"exchange":"NASDAQ","name":"Lantheus Holdings, Inc.","nameEN":"Lantheus"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.32.1","shortVersion":"4.32.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Lantheus Holdings, Inc.(LNTH)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Lantheus Holdings, Inc.(LNTH)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Lantheus Holdings, Inc.,LNTH,Lantheus Holdings, Inc.股票,Lantheus Holdings, Inc.股票老虎,Lantheus Holdings, Inc.股票老虎国际,Lantheus Holdings, Inc.行情,Lantheus Holdings, Inc.股票行情,Lantheus Holdings, Inc.股价,Lantheus Holdings, Inc.股市,Lantheus Holdings, Inc.股票价格,Lantheus Holdings, Inc.股票交易,Lantheus Holdings, Inc.股票购买,Lantheus Holdings, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Lantheus Holdings, Inc.(LNTH)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Lantheus Holdings, Inc.(LNTH)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}